Highlights
- 1The Journal of clinical investigation · 2023
Publications
25 publications
Funding
5 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- Co-IR01AI174064-01A1Immune Privilege, CNS Autoimmunity, and Clostridium perfringens Epsilon ToxinNational Institute of Allergy and Infectious Diseases · 2023–2028
- Co-IRG-2512-45549Harboring the Initial Trigger of Multiple SclerosisNational Multiple Sclerosis Society · 2023–2026
- Co-IRR-1602-07671Quantitative MRI of Lesion Iron and Myelin RepairNational Multiple Sclerosis Society · 2016–2025
Completed grants (2)
- KPBP 234223-01Biopharma Agreement with Astoria BiologicaAstoria Biologica · 2023–2025BioPharma Alliance
- Co-IR01NS104350-01Damage Associated Molecular Patterns and Regenerative Failure in MSNational Institute of Neurological Disorders and Stroke · 2017–2023
News mentions
1 mentionView all WCM news ↗
- Study Finds Bacterial Toxin May Trigger Multiple Sclerosis Onset and RelapseMarch 24, 2023
A specific toxin-producing gut bacteria may be responsible for both triggering the onset of multiple sclerosis (MS) and ongoing disease activity.
External relationships
Proprietary Interest
Astoria Biologica
Other
Astoria Biologica